Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer

NCT00079287 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: docetaxel
DRUG: gemcitabine hydrochloride
DRUG: paclitaxel
DRUG: vinorelbine tartrate

Sponsor

Japan Multinational Trial Organization